Peptide-based inhibitors of protein–protein interactions P Wójcik, Ł Berlicki Bioorganic & medicinal chemistry letters 26 (3), 707-713, 2016 | 200 | 2016 |
Distinct local and systemic molecular signatures in the esophageal and gastric cancers: possible therapy targets and biomarkers for gastric cancer I Bednarz-Misa, P Fortuna, D Diakowska, N Jamrozik, ... International journal of molecular sciences 21 (12), 4509, 2020 | 24 | 2020 |
Altered L-arginine metabolic pathways in gastric cancer: potential therapeutic targets and biomarkers I Bednarz-Misa, MG Fleszar, P Fortuna, Ł Lewandowski, ... Biomolecules 11 (8), 1086, 2021 | 22 | 2021 |
L-arginine/nitric oxide pathway is altered in colorectal cancer and can be modulated by novel derivatives from oxicam class of non-steroidal anti-inflammatory drugs M Krzystek-Korpacka, B Szczęśniak-Sięga, I Szczuka, P Fortuna, ... Cancers 12 (9), 2594, 2020 | 20 | 2020 |
Controlling the Helix Handedness of ααβ‐Peptide Foldamers through Sequence Shifting M Szefczyk, E Węglarz‐Tomczak, P Fortuna, A Krzysztoń, ... Angewandte Chemie International Edition 56 (8), 2087-2091, 2017 | 20 | 2017 |
Interleukins 4 and 13 and their receptors are differently expressed in gastrointestinal tract cancers, depending on the anatomical site and disease advancement, and improve … I Bednarz-Misa, D Diakowska, I Szczuka, P Fortuna, A Kubiak, ... Cancers 12 (6), 1463, 2020 | 17 | 2020 |
Systematic ‘foldamerization’of peptide inhibiting p53-MDM2/X interactions by the incorporation of trans-or cis-2-aminocyclopentanecarboxylic acid residues P Fortuna, A Twarda-Clapa, L Skalniak, K Ożga, TA Holak, Ł Berlicki European Journal of Medicinal Chemistry 208, 112814, 2020 | 15 | 2020 |
Low metformin dose and its therapeutic serum concentration in prediabetes E Sutkowska, P Fortuna, J Wisniewski, K Sutkowska, P Hodurek, ... Scientific Reports 11 (1), 11684, 2021 | 13 | 2021 |
Sitagliptin modulates oxidative, nitrative and halogenative stress and inflammatory response in rat model of hepatic ischemia-reperfusion M Trocha, MG Fleszar, P Fortuna, Ł Lewandowski, ... Antioxidants 10 (8), 1168, 2021 | 11 | 2021 |
Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients … MG Fleszar, P Fortuna, M Zawadzki, B Kosyk, M Krzystek-Korpacka Molecules 25 (21), 5158, 2020 | 11 | 2020 |
Metformin has no impact on nitric oxide production in patients with pre-diabetes E Sutkowska, P Fortuna, B Kałuża, K Sutkowska, J Wiśniewski Biomedicine & Pharmacotherapy 140, 111773, 2021 | 8 | 2021 |
A computationally designed β-amino acid-containing miniprotein M Bejger, P Fortuna, M Drewniak-Świtalska, J Plewka, W Rypniewski, ... Chemical Communications 57 (49), 6015-6018, 2021 | 8 | 2021 |
Esophageal squamous cell carcinoma is accompanied by local and systemic changes in L-arginine/NO pathway I Bednarz-Misa, P Fortuna, MG Fleszar, Ł Lewandowski, D Diakowska, ... International Journal of Molecular Sciences 21 (17), 6282, 2020 | 8 | 2020 |
Increased intraplatelet ADMA level may promote platelet activation in diabetes mellitus J Gawryś, J Wiśniewski, E Szahidewicz-Krupska, D Gajecki, J Leśniewska, ... Oxidative Medicine and Cellular Longevity 2020 (1), 6938629, 2020 | 6 | 2020 |
Covalent and noncovalent constraints yield a figure eight-like conformation of a peptide inhibiting the menin-MLL interaction P Fortuna, BM Linhares, T Purohit, J Pollock, T Cierpicki, J Grembecka, ... European Journal of Medicinal Chemistry 207, 112748, 2020 | 4 | 2020 |
A cross-talk between the erythrocyte l-arginine/ADMA/nitric oxide metabolic pathway and the endothelial function in subjects with Type 2 diabetes mellitus D Gajecki, J Gawryś, J Wiśniewski, P Fortuna, E Szahidewicz-Krupska, ... Nutrients 13 (7), 2306, 2021 | 3 | 2021 |
The impact of Sample Handling Time on metformin serum concentration E Sutkowska, P Fortuna, B Kałuża, K Sutkowska, P Hodurek, MG Fleszar Biomedicine & Pharmacotherapy 133, 110971, 2021 | 3 | 2021 |
Effect of Obstructive Sleep Apnea and CPAP Treatment on the Bioavailability of Erythrocyte and Plasma Nitric Oxide J Mochol, J Gawryś, E Szahidewicz-Krupska, J Wiśniewski, P Fortuna, ... International Journal of Environmental Research and Public Health 19 (22), 14719, 2022 | 2 | 2022 |
Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke—A Dynamic Human LC/MS Metabolomic Study M Bladowski, E Szahidewicz-Krupska, J Wiśniewski, P Fortuna, ... Antioxidants 11 (5), 955, 2022 | 2 | 2022 |
Measurement of serum levels of 5 amino acids and dimethylamine using Liquid Chromatography-Tandem Mass Spectrometry in Patients without Septic Associated Acute kidney Injury … P Leśnik, L Łysenko, MG Fleszar, P Fortuna, E Woźnica-Niesobska, ... Medical Science Monitor: International Medical Journal of Experimental and …, 2022 | 2 | 2022 |